Eurofins SAFER@WORK: A runway back to flight in COVID-19 times

Supported by:

10 February 2021

Supported by:

10 February 2021


The airline industry connects everything that matters most – our families, homes, and food logistics; our businesses and governments. The next normal depends critically on our safe return to flight.

As a world leader in the provision of clinical diagnostics, forensic, pharmaceutical, food and environmental laboratory testing services, Eurofins is uniquely positioned to provide comprehensive, fast, reliable, customised COVID-19 testing, monitoring, and consultation solutions for virtually any industry, around the globe.

The Eurofins SAFER@WORK™ programmes are designed to help you to set up advanced risk management protocols to contribute to limiting the impact of COVID-19 on your workplace.

Key Learning Points

  • Identify the right testing and monitoring programme to get your airport back to full operations and flying again
  • Learn how Eurofins provides critical testing from departure, through flight and upon arrival
  • Learn about how each testing protocol can contribute to the safety of your passengers and staff, including people, water, air, surface, and mask
  • Learn how Eurofins can develop comprehensive, robust, customised testing, monitoring and consulting plans for each unique airport site
  • Gain valuable insight into the if-then scenarios of testing and monitoring.

End-to-End Solutions

The Eurofins SAFER@WORK™ approach balances passenger convenience, safety, and workplace confidence with flexible options designed to suit the airline industry, all while aligning with respective regulatory guidelines.

Foster Peace of Mind for Travellers

Provide seamless pre-travel testing solutions and collection services for planned travellers designed by Eurofins epidemiologists. Create a safe environment yielding peace of mind for your travellers so that they feel confident to take flight again.

Proactively Manage Employee Health

With over 30 years’ experience in infectious disease testing, the capacity to perform millions of tests per week, and the most comprehensive global network of laboratories, Eurofins ensures you can affordably provide access to fast, reliable testing for passengers and employees. Medical staff, collection services, and courier logistics provide easy solutions for your complex business.

Maintain and Monitor Site Hygiene

In high traffic areas, it is imperative to verify the effectiveness of your disinfection measures to limit the spread of coronavirus. Surface, air, and wastewater testing for coronavirus|SARS-CoV-2 can also be used to understand how and where coronavirus is moving throughout your facility and vessels.

Eurofins is Testing for Life. Find your solution.

Keynote Speakers

Keynote Speakers

Eurofins SAFER@WORK - Adarsh MurthyAdarsh Murthy, CEO SAFER@WORK Europe, Eurofins

Nina Constantine - SAFER@WORKNina Constantine, Eurofins Food and Environment Director, Eurofins Genomics

David Havera - SAFER@WORKDavid Havera, General Manager – Blockchain Solutions, GE Digital

David leads the Blockchain Solutions portfolio within the aviation vertical at GE Digital. His goals are balanced between breaking even on the bottom line while driving top line sales growth and adoption. The business model is heavily partner driven. He not only works very closely with Microsoft, Eurofins, and TE FOOD, but also is recruiting new partners to expand the business model and service offerings.

David brings a wealth of GE experience (15+ years) and technology experience. David has over 10 years of corporate finance background at GE including site finance manager roles at Hamble, UK and Ellisville, MS and numerous years as a Data Scientist and Blockchain SME.

Steven - SAFER@WORKSteven B. Kleiboeker, PhD, Chief Scientific Officer, Eurofins US Clinical Diagnostics

Steven B. Kleiboeker, PhD, is the Chief Scientific Officer for Eurofins US Clinical Diagnostics. Dr. Kleiboeker’s work is focused on viral and immunological diagnostics with a specialisation in molecular techniques. He performs research in the areas of viral pathogenesis, phylogenetics and immunology. His work has included projects on a broad range of human and animal pathogens.

He has published over 70 refereed scientific articles and three book chapters. Dr. Kleiboeker has served as principal and co-investigator on research grants that were funded by governmental agencies, commodity groups and private entities. Dr. Kleiboeker is certified in molecular diagnostics as a high complexity laboratory director (HCLD), technical specialist and clinical consultant by the American Board of Bioanalysis. Prior to joining Viracor Eurofins in 2005, he was a faculty member at the University of Missouri where his duties included research, teaching of graduate and professional students, and supervision of diagnostic service laboratories (virology, serology and molecular diagnostics).

Watch On-Demand

Register to watch this webinar on-demand

    Unless making a secure payment with your credit or debit card via a third-party payment processor, this form is not designed to collect confidential or sensitive personal information (e.g., financial information, social security numbers).

    *Required field

    Your details







    Other information

    Email preferences

    If you’re not already opted-in to receive our emails, please select which types of communication you would like to receive:

    Confirm that you're human

    By clicking register, you consent to International Airport Review contacting you about this and future webinars, and that you agree to our terms and conditions and privacy policy. Your information will be processed in accordance with GDPR and you can unsubscribe at any time.

    One response to “Eurofins SAFER@WORK: A runway back to flight in COVID-19 times”

    1. Excellent publication

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Send this to a friend